{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":13,"n_cols":5,"rows_kept":13,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910583394903321"]
[null,null,"Titolo",null,"Translational immunotherapy of brain tumors / / editor, John H. Sampson"]
[null,null,"Pubbl/distr/stampa",null,"London : , : Academic Press, an imprint of Elsevier, , [2017]"]
[{"$nulls":4},"©2017"]
[null,null,"ISBN",null,"0-12-802625-1"]
[null,null,"Descrizione fisica",null,"1 online resource (406 pages) : illustrations"]
[null,null,"Disciplina",null,"616.99/481"]
[null,null,"Soggetti",null,"Brain - Tumors - Immunotherapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"An introduction to immunotherapy in the treatment of brain tumors / J.M. Komisarow and J.H. Sampson -- Immune constitution of patients with brain tumors / J. Berry-Candelario, S.H. Farber and P.E. Fecci -- The role of regulatory t cells and indolamine-2,3-dioxygenase in brain tumor immunosuppresion / M. Dey, A.L. Chang, J. Miska, J. Qiao and M.S. Lesniak -- The role of myeloid-derived suppressor cells in immunosuppresion in brain tumors / K. Gabrusiewicz, N.A. Colwell, and A.B. Heimberger -- Tumor-specific mutations in gliomas and their implications for immunotherapy / C.J. Pirozzi, A.B. Carpenter, T. Hennika, O.J. Becher and H. Yan -- Preclinical immunotherapeutic animal models fo brain tumors / V. Chandramohan, L. Sanchez-Perez, Y. He, C.J. Pirozzi, K.L. Congdon and D.D. Bigner -- Imaging studies in immunotherapy / R.Y. Huang and D.A. Reardon -- Immunotherapy clinical trials in neuro-oncology / S. Khagi and G. Vlahovic -- Peptide-specific vaccines / P. Roth and M. Weller -- Immunotoxin therapy for brain tumors / V. Chandramohan, J.H. Sampson, I.H. Pastan and D.D. Bigner -- Checkpoint blockade immunotherapy for glioblastoma / K.A. Riccione, P. Gedeon, L. Sanchez-Perez and J.H. Sampson -- Dendritic cell therapy for brain tumors / R.G. Everson, J.P. Antonios, A.M. Tucker and L.M. Liau -- Adoptive immunotherapy against brain tumors / C. Flores, D. Mitchell and P.A. Wells -- Chimeric antigen receptor therapy of brain tumors / L. Sanchez-Perez, C.M. Suryadevara, B.D. Choi and L.A. Johnson."]